Searching for the silver lining
While the pharmaceutical industry is researching drugs and delivery systems specifically targeted at geriatric patients, dealing…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Management
Patents in pharma industry in India
An overview on patent applications by Tarun Bansal, Founder, Sagious Research
Rupee’s fall from grace: A blessing in disguise?
How will the falling Rupee impact Indian pharma Inc? While some feel it's an unmitigated disaster, others call it a blessing in…
Boehringer Ingelheim India: Revving up
As BI India completes a decade of operations in India, Sharad Tyagi, chairman and managing director, BI India gives details of the…
Gearing up for the future
Usha Sharma seeks the views of industry stalwarts on the recent upheavals in the Indian pharma regulatory system and finds that…
Raise your game – Expand your horizons in the Indian OTC market
Sreedevi Yallamrazu, Sr Strategic Analyst, CubeX, provides a snapshot of the dynamics of the Indian OTC market and various…
Pioglitazone: The Saga Continues
Medical practitioners, pharma companies and patients heave a sigh of relief after MoHFW revoked the ban on pioglitazone. Usha…
US Supreme Court squares off on human gene patentability
Smriti Subramanian, Partner, and Anumeha Iyer, Associate, Advaya Legal dissect the split legal outcome of the decision by the US…
Fair decision
DIPP's proposal to hike patent application fees and levy a surcharge on hard copy filings result is justified only if there is a…
HTA is still unstructured and nascent in the Indian context
Utkarsh Palnitkar, Partner & Head, Transactions & Restructuring & National Leader - Life sciences practice at KPMG…
Viral hepatitis: The era of molecular assays
Dr Faisal Khan, Sr Research Officer-Knowledge Management R&D, SRL gives an outlook on the burgeoning morbidity and mortality…
Patent protection for orphan drugs
With the increase in orphan drug registrations and high revenue potential prediction; it has become crucial for companies to…
Drugs no more
Treated as drugs for long under the Drugs and Cosmetics Act, the fate of medical devices seems to be headed for a turnaround with…
eDetailing: The future for pharma communication?
Dinesh Chindarkar, Co-founder, MediaMedic Communications elucidates about eDetailing – where technology and graphics, married with…
B(LO)w and behold!
It all started when Dinesh Thakur blew the whistle. Shalini Gupta takes a look at where does India stand on whistleblower policy,…
Insights in data science and its applications
Data science will contribute more to reducing costs and increasing effectiveness than the drugs themselves, says Reenita Das,…
A stitch in time saves nine – Publication of non-worked patents
Publication of list of non-worked patents by Patent Office is not prohibited by TRIPs but is a globally neglected phenomenon-…
DPCO 2013: A fair move or a misstep?
The DPCO 2013 issued by the DOP covers the prices of 652 formulations in over 27 therapeutics. Usha Sharma talks to industry…
Nutraceuticals on the move
Suhas Wadwalkar, Vice President — Corporate Affairs, Premier Nutraceuticals, focuses on the fresh and emerging segment of…
Whistleblower Protection in India Delay in framing legal enactment will harm the public interest
Rajdutt Shekhar Singh, Principal Associate, Singh and Associates gives an insight about the protection which needs to be provided…